MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 7 filers reported holding MYRIAD GENETICS INC in Q2 2012. The put-call ratio across all filers is 0.75 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,192 | -46.8% | 199 | -23.2% | 0.00% | – |
Q2 2023 | $6,004 | +46.9% | 259 | +47.2% | 0.00% | – |
Q1 2023 | $4,088 | +60.1% | 176 | 0.0% | 0.00% | – |
Q4 2022 | $2,554 | -14.9% | 176 | 0.0% | 0.00% | – |
Q3 2022 | $3,000 | 0.0% | 176 | 0.0% | 0.00% | – |
Q2 2022 | $3,000 | -25.0% | 176 | 0.0% | 0.00% | – |
Q1 2022 | $4,000 | -20.0% | 176 | 0.0% | 0.00% | – |
Q4 2021 | $5,000 | -16.7% | 176 | 0.0% | 0.00% | – |
Q3 2021 | $6,000 | -50.0% | 176 | -55.8% | 0.00% | – |
Q2 2021 | $12,000 | 0.0% | 398 | 0.0% | 0.00% | – |
Q1 2021 | $12,000 | +50.0% | 398 | 0.0% | 0.00% | – |
Q4 2020 | $8,000 | +300.0% | 398 | +126.1% | 0.00% | – |
Q3 2020 | $2,000 | 0.0% | 176 | 0.0% | 0.00% | – |
Q2 2020 | $2,000 | -33.3% | 176 | -11.1% | 0.00% | – |
Q1 2020 | $3,000 | -40.0% | 198 | 0.0% | 0.00% | – |
Q4 2019 | $5,000 | -16.7% | 198 | 0.0% | 0.00% | – |
Q3 2019 | $6,000 | 0.0% | 198 | 0.0% | 0.00% | – |
Q2 2019 | $6,000 | -14.3% | 198 | 0.0% | 0.00% | – |
Q1 2019 | $7,000 | +16.7% | 198 | 0.0% | 0.00% | – |
Q4 2018 | $6,000 | -33.3% | 198 | 0.0% | 0.00% | – |
Q3 2018 | $9,000 | +28.6% | 198 | 0.0% | 0.00% | – |
Q2 2018 | $7,000 | +16.7% | 198 | 0.0% | 0.00% | – |
Q1 2018 | $6,000 | -14.3% | 198 | 0.0% | 0.00% | – |
Q4 2017 | $7,000 | -12.5% | 198 | -10.4% | 0.00% | – |
Q3 2017 | $8,000 | +100.0% | 221 | +46.4% | 0.00% | – |
Q2 2017 | $4,000 | -96.8% | 151 | -95.9% | 0.00% | -100.0% |
Q2 2015 | $126,000 | -98.5% | 3,707 | -98.3% | 0.00% | -98.3% |
Q3 2014 | $8,485,000 | +13.6% | 220,000 | +14.7% | 0.17% | +18.4% |
Q2 2014 | $7,467,000 | +20.4% | 191,860 | +5.7% | 0.15% | +23.5% |
Q1 2014 | $6,203,000 | +5751.9% | 181,438 | +3490.7% | 0.12% | +3866.7% |
Q4 2013 | $106,000 | -10.9% | 5,053 | -0.4% | 0.00% | -25.0% |
Q3 2013 | $119,000 | 0.0% | 5,071 | +14.4% | 0.00% | 0.0% |
Q2 2013 | $119,000 | +54.5% | 4,432 | +46.9% | 0.00% | +100.0% |
Q1 2013 | $77,000 | +4.1% | 3,016 | +11.8% | 0.00% | -33.3% |
Q4 2012 | $74,000 | +146.7% | 2,698 | +145.3% | 0.00% | +200.0% |
Q3 2012 | $30,000 | +42.9% | 1,100 | +22.2% | 0.00% | 0.0% |
Q2 2012 | $21,000 | 0.0% | 900 | 0.0% | 0.00% | 0.0% |
Q1 2012 | $21,000 | +10.5% | 900 | 0.0% | 0.00% | 0.0% |
Q4 2011 | $19,000 | +111.1% | 900 | +80.0% | 0.00% | – |
Q3 2011 | $9,000 | -81.2% | 500 | -71.5% | 0.00% | -100.0% |
Q3 2009 | $48,000 | -23.8% | 1,753 | -0.8% | 0.00% | -33.3% |
Q2 2009 | $63,000 | -47.9% | 1,768 | -33.5% | 0.00% | -57.1% |
Q1 2009 | $121,000 | – | 2,657 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |